FDA Updates Label for Regeneron's Dupixent in Atopic Dermatitis With Uncontrolled Hand and Foot Involvement

Dupixent is an IL-4 receptor alpha antagonist that has been approved for the treatment of adults with moderate-to-severe atopic dermatitis, as well as asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis.

Leave a Reply

Your email address will not be published. Required fields are marked *